Conversion of ER and HER2 Status After Neoadjuvant Therapy in Chinese Breast Cancer Patients. Bo J, Yu B, Bi R, Xu X, et al. Clin Breast Cancer 2023 Mar 8:S1526-8209(23)00056.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bo J, Yu B, Bi R, Xu X, et al. Conversion of ER and HER2 Status After Neoadjuvant Therapy in Chinese Breast Cancer Patients. Clin Breast Cancer 2023 Mar 8:S1526-8209(23)00056.
PMID: 36990841